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The advantages, disadvantages, and uses of serological epidemiology are discussed in
relation to acute respiratory infections in military personnel. The prevalence of antibody
reflects both current and past experience with respiratory agents and is a measure of suscepti-
bility. Incidence data calculated by testing two serial serum samples, on entry and discharge
from the service, has indicated high influenza and Mycoplasma pneumoniae rates in South
American recruits and low rates ofadenovirus and parainfluenza infections. Serologic analysis
of reinfection rates showed high protection against influenza infections at HI antibody levels of
over 1:40, against adenovirus infections at neutralizing titers of 1:5, and against M. pneu-
moniae infections at TRI antibody levels over 1:8. Antibody responses persisting at least 7 mo
following immunization were demonstrated in 70% of428 vaccinated young adults for A2 an-
tigen and 20% for influenza B antigen. No relation of ABO blood groups to respiratory in-
fection was found. The lack of myxovirus infections in four Polaris submarines is presented.
Most data on the incidence of acute respiratory infections in military personnel
are based on reporting systems that record cases ofdisease which are hospitalized or
seen in outpatient clinics. Information derived from these sources are presented in
the other articles ofthis symposium.
This paper will discuss the advantages and disadvantages of serological epide-
miology in acute respiratory infections ofmilitary personnel and presents the results
of various studies illustrating the uses of this technique. The examples will be drawn
from our own published and unpublished work carried out under the sponsorship of
the Commission on Viral Infections of the Armed Forces Epidemiological Board3
or in association with the Naval Submarine Medical Laboratory, Groton, Conn.
DEFINITION
Serological epidemiology can be defined as the systematic testing of blood sam-
ples from a defined population for antibodies to various microbiological agents. A
book (1) and two WHO Expert Committee Reports (2, 3) deal with the
methodology.
'The work on which this paper is based was carried out under the sponsorship of the Commission on
Viral Infections of the Armed Forces Epidemiological Board and was supported by the U.S. Army Re-
search and Development Command, under research Contract No. DADA 17-69-C-9172 and with support
from Grants from the World Health Organization and from the National Aeronautics and Space
Administration (NGR-004-146).
2Presented in Symposium on Acute Respiratory Diseases of Military Significance, Society of Medical
Consultants to the Armed Forces, November 17, 1974, Arlington, Virginia.
3Under research contract DADA17-69-C-9172.
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TABLE 1
Advantages of Serological Surveys
1. Indicates cumulative prevalence rates of current and past infections
2. Reflects both clinical and subclinical infections and epidemics
3. Can measure the incidence of infection in two sera spaced in time
4. Relates infection rates and protection to preexisting antibody levels
5. In immunization programs measures
a. Need for immunization
b. Percentage of seroconversion following immunization
c. Quantity and quality of antibody produced
d. Duration of antibody and protection
e. Reinfection rates.
ADVANTAGES AND DISADVANTAGES
The major advantages of serological surveys over case-reporting methods are
listed in Table 1. The most important of these are (1) the ability to determine both
current and past experiences of a group with various microbial agents (cumulative
prevalence) and (2) the measurement of both clinical and subclinical infections. The
majority of the respiratory agents infecting military personnel result in a large
number of inapparent or very mild illnesses which would be missed by the case-
reporting system. Data systems based on the reporting of disease are notoriously
inadequate; similarly, problems may arise in the collection and analysis of out-
patient or even hospitalization admission or discharge records. It may also be
difficult to define the appropriate denominator in calculating rates for a mobile
recruit population. Serologic techniques avoid some of these problems and do not
depend on historical or clinical information.
The disadvantages are the necessity and cost of obtaining a blood sample from a
representative segment of the population and the work involved in performance of
antibody tests. This author would emphasize that the benefits far outweigh the
disadvantages in most situations.
PREVALENCE
The presence of antibody on entrance into military service reflects the prior
experience of the recruits with the antigens employed in the test and indicates the
level of susceptibility. The hemagglutination-inhibition (HI) antibody measured in
surveys for influenza virus is long-lasting so that a pattern ofcumulative prevalence
is revealed by the test. These correlated closely with protection against infection and
disease. Persons who have no HI antibody at the lowest dilution tested, usually
1:10, can be regarded as susceptible to infection and those with titers over 1:40 as
immune. For the adenoviruses, antigen-specific neutralization tests should be used
although antibody to some types can be measured by a hemagglutination-inhibition
test. For Mycoplasmapneumoniae either the tetrazolium-inhibition reduction (TRI)
or the metabolic-inhibition tests are good epidemiologic tools to indicate suscepti-
bility and immunity.
The prevalence of antibody to a variety of respiratory antigens is summarized in
Table 2 for Argentine (4, 5) and Colombian recruits (6, 7) on entry into the service as
compared to U.S. Peace Corps Volunteers (7) in Colombia using sera taken before
leaving the U.S. for duty in South America. Most persons in all three groups
possessed antibody to current influenza A strains. However, the low level of 18%
prevalence to A2/Hong Kong/68 in Argentine recruits bled in that same year indi-
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TABLE 2
Antibody Status of Argentine and Colombian Recruits and Peace Corps Volunteers
in Colombia at Time of Entry into the Service
Peace Corps in
Argentine recruits Colombian recruits Colombia
Virus Test used Antigen Year No. Percent Year No. Percent Year No. Percent
group levele pos. used bled tested positive bled tested positive bled tested positive
Infl. A HI A2/Jap/ 65/66 328 92 66A 296 91
(1: 10) A2/Tai/64 68 143 88 66B 346 88 64 208 36
A2/HK/68 68 143 18
Infl. B HI B/GL/54 65/66 328 64 66A 296 75
(1:10) B/Md/59 65/66 328 49 66A 142 83
B/GL/54 68 143 92
B/Md/59 68 143 45 66B 346 67 64 208 41
Para 1 HI Type 1 65/66 328 64 66A 285 80
(1:10-20) 68 143 60 66B 346 85 64 208 33
1:20
Para 2 HI Type 2 65/66 328 84 66A 288 74
(1:10-20) 68 143 35 66B 346 86 64 208 25
Para 3 HI Type 3 65/66 328 33 66A 288 99
(1:10-20) 68 143 99 66B 346 94 64 208 80
Adeno Neut. Type 3 68 140 28 66B 346 0 64 201 31
(or HI)a Type 4 68 140 21 Not tested Not tested
1:5 Type 7 68 140 8 66B 346 16 64 201 21
M. pneu. TRI 68 138 66 66B 176 50 64 111 49
(1:1)
aHI tests used for adenovirus 3 and 7 in Colombia Recruits and Peace Corps Volunteers. HI = Hem-
agglutination-inhibition. NEUT. = Neutralization test. TRI = Tetrazolium-reduction-inhibition test.
cated that the epidemic had not yet reached there and vaccination would have been
desirable; similarly antibody to A2/Tai/64 was present in only 36% of Peace Corps
Volunteers bled in that year.
Antibody prevalence levels to influenza B/GL/1959 were generally below 50% in
all three populations tested, again indicating the need for this vaccine.
Parainfluenza vaccines are not available but with a few exceptions antibody preva-
lence rates were high.
Adenovirus vaccine for types 4 and 7 is available and in use in the U.S. Armed
Forces because of the high infection rates to these strains during recruit training.
These are discussed in another paper in this symposium (8). The low antibody preva-
lence rates to adenovirus types 4 and 7 in the populations tested as well as to type 3
indicate a high level of susceptibility in South American recruits and in the U.S.
Peace Corps group at the time when they entered service.
Antibody to M. pneumoniae as measured by the TRI or metabolic-inhibition tests
was present in only about half of the three groups tested, again indicating a large
group of susceptibles. The potential morbidity from these patterns of susceptibility
will depend on the activity of the agent in the group and on the degree of exposure.
These are discussed below.
INCIDENCE
The incidence ofinfection can be measured in a population between two points in
time by comparing antibody titers taken from the same persons at the start and at
the end of this period. Infection is indicated either by the appearance of antibody in
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TABLE 3
Overall Incidence Rates
Percentage showing antibody rise
Argentine recruits Colombia recruits Colombia Peace Corps
No. First Next No. First No. First Next
Antigen tested 3 mo 9
mo tested 23 mo tested 15 mo 7 mo
Influenza A 142 72.5 0.7 346 39.0 205/41 10.7 2.4
B 142 0 346 13.6 205/41 2.0 2.4
Parainfluenza 1 142 1.7 3.5 346 4.9 205/41 0 0
2 1.7 00 346 2.9 205/41 2.0 0
3 2.6 7.0 346 15.0 205/41 2.0 2.4
Adeno 3 135 0.7 7.9 346 0 197 0 NTa
4 140 0.0 0.7
7 139 0.7 8.4 346 6.3 197 0 NT
M.pneumoniae 138 18.1 12.3 176 17.0 111 22.3 NT
aNT = not tested.
the second sera when absent from the first or by the demonstration of a fourfold or
greater rise in antibody titer. Table 3 summarizes the infection rate of Argentine
recruits during 9 mo of service (5) Colombian recruits during 22 mo of service (7),
and of Peace Corps Volunteers serving 2 yr in Columbia, S.A. (7). Very high in-
fection rates to influenza A were seen in Argentine Recruits during the basic training
period involving almost three-fourths of the population; influenza B was essentially
absent. In 346 Colombian military recruits the infection rate for influenza A2 was
39% over 22 mo, for influenza B was 13.6%, and for parainfluenza viruses was
22.8%, mostly due to type 3. In total, 75.4% had a myxovirus infection during
military service (7). In 201 Colombian Peace Corps volunteers 16.6% had myxovirus
infections in the first 15 mo; in 41 of these volunteers followed over 7 mo 7.3% had a
myxovirus infection (7). The much higher infection rate in recruits as compared to
the Peace Corps group was shown to be due both to higher susceptibility and to
higher exposure.
Adenovirus infections which were so common in U.S. recruits during basic
training prior to the use of type 4 and 7 vaccine (8) produced few infections in 135
Argentine recruits tested at the start and end of their basic training by neutralization
tests. Only 9 infections to type 3 (0.7%) and 9 to type 7 (0.7%) were demonstrated in
135 recruits during basic training; no serologic evidence of infection to type 4 was
seen in 140 recruits tested. There was evidence of adenovirus infections in the subse-
quent 9 mo involving 7.9% with type 3 and 8.4% with type 4; only 10 type 4 infections
(0.7%) were found.
In the Columbian group, tests for adenovirus antibody were made by hemaggluti-
nation-inhibition tests. Very low infection rates were observed: in 346 recruits tested
none showed serologic evidence to type 3 adenovirus and only 6.3% to type 7; in 197
Peace Corps volunteers none had evidence of infection by either type. Type 4 anti-
body was not tested because of technical difficulties.
Infections with M. pneumoniae which are important in U.S. recruits (9) also
proved to be important in South American recruits both during basic training and
subsequently. In Argentine recruits 18.1 % experienced infections during the first
three mo and 12.3% in the next 9 mo; in Colombian recruits 17% were infected over
23 mo. Mycoplasma pneumoniae was the most important cause of respiratory in-
fection in the Peace Corps group with 22.3 showing antibody rises over the first 15
mo.
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TABLE 4
Infection Rates in Persons Lacking Antibody
Argentine recruits Colombian recruits Peace Corps Volunteers
Number of Number of Number of
Type susceptibles Rate/i 00 susceptiblesa Rate/100 susceptiblesa Rate/100
Influenza A 16 100 125 64.0 25 40
B 16 18.7 205 19.0 68 7.3
Adenovirus 3 100 12.0 331 0 139 0
4 110 0.9
7 128 10.1 277 7.2 158 0.6
M. pneumoniae 44 45.4 97 30.9 57 46.2
aLacking antibody in lowest dilution tested.
INCIDENCE IN SUSCEPTIBLES
The data presented above are based on the overall infection rates without
considering the initial antibody status of the groups. Serological techniques also
permit calculation of incidence rates in susceptibles, i.e., those lacking antibody.
Under such conditions the resulting rate probably reflects the intensity ofexposure.
Table 4 presents an analysis of the data in this way. In susceptible recruits influenza
A had rates of 40-100%, adenovirus type 7 of 0.6-10%, and M. pneumoniae of 31-
45%. Knowledge of the infection rates and of the antibody prevalence rates of new
recruits would provide a basis for estimating the number ofinfections that might oc-
cur. Unfortunately, this does not indicate the number who might become clinically
ill. This type of information must be obtained from case reports and clinical sur-
veillance. One analysis of this type was done in Yale University students during
their freshman year at a period when influenza was epidemic (10). On entry, tests
were made on 281 students ofwhom only 8.9% had preexisting antibody at low levels
to the infecting strain. Of 273 paired sera obtained at the start and end of the year
45.2% showed serologic evidence of infection; of those infected 59% had clinical
symptoms of respiratory disease. Similar data have been reported by Davis et al.
(11). Given infection rates of50-100% for epidemic influenza in a recruit setting and
a clinical illness rate of about 60%, some 30-60% of the population can be expected
to become clinically ill during basic training. Such estimates provide unequivocal
testimony to the need for routine immunization of recruit populations against
influenza using the most recent viral antigens in the vaccine. In a comprehensive
summary of this practice in U.S. recruits over many years a vaccine effectiveness of
70-90% has usually been found (12).
REINFECTION
The occurrence of reinfection can be determined by prospective serologic surveys
of naturally infected or vaccinated subjects. Table 5 summarizes analyses of this
type and includes, for comparison, the attack rate in those lacking antibody. It can
be seen that the risk of reinfection decreases sharply with increasing levels of
preexisting antibody. For influenza A very low reinfection rates were observed at an-
tibody levels over 1:40 and for influenza B at levels over 1:10. Such antibody levels
would be desirable to attain in immunization programs. While levels of nasal secre-
tory antibody are undoubtedly ofimportance in protection against natural infection,
the levels measured in tests for humoral antibody are also correlated with protection
and are simpler to perform.
The relation of antibody levels to reinfection to M. pneumoniae as determined by
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TABLE 5
Relation of Infection Rates in Recruits to Prior Antibody Levelsa
Infection rates
Influenza A Influenza B
Test Prior antibody level No. tested Rate No. tested Rate
HI <1:10 166 63.8 205 19.0
1:10 206 40.8 86 9.3
1:20 143 32.9 25 0
1:40 99 20.2 20 0
>1:40 82 6.0 10 0
M. pneumoniae
Test Prior antibody level No. tested Infection rate
TRI <1:2 44 45.4
1:2 27 25.9
1:4 43 32.6
1:8 16 6.2
>1:8 28 0
aThis table incorporates data from both Argentine (5) and Colombia (7) military recruits.
the tetrazolium reduction-inhibition test revealed a decreasing infection rate with in-
creasing antibody level and no infections over a titer of 1:8. Monto et al. (13)
reported reinfection rates of22.0% in the presence ofpreexisting complement-fixing
antibody but did not record the levels. Steinbert et al. (14) have found that the rate
of M. pneumoniae infection in Marine recruits correlated well with the level of
preexisting growth inhibition antibody; when infection occurred in seropositive indi-
viduals its severity was inversely related to the level ofpreexisting antibody.
IMMUNIZATION PROGRAMS
The use of serological surveys in defining the need for immunization programs has
already been mentioned. Other uses are listed in Table 1 and the serologic evaluation
of response to adenovirus vaccines will be discussed in the paper by Top (8). An
example of HI antibody responses to influenza vaccine in 428 cadets at the U.S.
Military Academy is presented in Table 6 as measured in sera taken on entry into
the Academy in July 1969, and approximately 1 yr later, in June 1970 (15). Influenza
vaccine consisting ofA2/HK, A2/Ann Arbor and B/Mass antigens had been given in
two doses of0.5 each November 1969, 7 mo prior to the second bleeding. The tests
used cannot differentiate between a response to immunization and a response to
TABLE 6
H.I. Antibody Responses to Homologous Antigens 9 mo after Influenza Immunization
in 428 Cadets at the U.S. Military Academy in Relation to Preexisting Antibody Levels
Preexisting antibody titers
Test antigen <10 10 20 40 80 160 >320 Totals
A2/Hong Kong
No. tested 176 68 52 59 45 17 11 428
Percent with antibody risea 69.8 51.4 55.7 25.4 8.8 5.8 9.9 48.5
B/Mass.
No. tested 36 65 87 123 62 38 17 428
Percent with antibody risea 83.3 53.8 22.9 10.5 3.2 0 0 20.3
aFourfold or greater rise in hemagglutination-inhibition (HI) antibody titer.
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natural infection between the two bleedings but no known outbreak ofinfluenza had
occurred and there was a low rate of respiratory admissions to the hospital.
Furthermore, many cadets developed antibodies to both A and B antigens and a
double natural infection would be unlikely. It is therefore probable that the
responses found were vaccine-induced and not naturally acquired. Fifty-eight per-
cent of the cadets already had prior antibody to the A2/Hong Kong antigen
contained in the vaccine at the time ofadministration; of 176 lacking antibody 69.8%
developed antibody levels which were still present 7 mo later. In those with prior an-
tibody at levels of 1:10 or higher a fourfold rise in titer occurred in 51.4% and the
frequency of this response diminished with increasing titers of preexisting antibody.
Similar results were seen with influenza B antigen; of36 lacking antibody at the time
of immunization 83.3% had demonstrable antibody 7 mo later; again a decreasing
frequency of response was observed with increasing levels of preexisting antibody.
Overall, 48.5% of the 428 cadets developed antibody rises that persisted 7 mo
against the homologous influenza A antigen following immunization and 20.3% de-
veloped persisting antibody rises to influenza B. The reason for the poorer response
to B antigen is not known but may reflect the smaller antigenic mass of influenza B
contained in the vaccine.
INFECTION IN A CLOSED ECOLOGIC SETTING
A prospective analysis of infection and illness rates for influenza and
parainfluenza viruses has been made in four Polaris submarine crews to determine
the risk of infection in a closed ecologic setting and the degree of spread in crew
members isolated for 2 mo on an undersea mission (16). Three serial serum samples
have been tested from over 500 crew members. The first sample was collected prior
to departure from the U.S. to an overseas base, a second just prior to the mission
after 3 wk on shore there in a "refitting operation," and the third at the end of an 8
wk underwater exercise. Antibody prevalence rates were very high at the start:
90.8% had HI antibody to A2Hong Kong, 78.8% to A2England, and 96.4 to B/GL or
B/Mass. Similar high antibody prevalence rates were seen for the three
parainfluenza viruses, ranging from 73.9 to 99.4%. Thishigh level ofprior protection
may explain the low rates of subsequent infection during the observation period: an-
tibody rises to A2/Hong Kong occurred in only 2.4%, to A2/England in 4.2%, and to
B strains in only 1.9% of the crew members. The total parinfluenza rate was 4.0%.
Minor respiratory illnesses, not identified serologically, were common during the
"refit period" in the community abroad but disappeared while on the mission. These
observations should not result in underestimating the possible spread of an in-
fectious agent under these circumstances if the population is a susceptible one.
Indeed, one outbreak ofM. pneumoniae with a 50% attack rate has been reported in
a Polaris submarine (17).
RISK FACTORS IN RELATION TO INFECTION
Prospective serological surveys permit measurement of the risk of infection in
relation to various attributes of the host or ofthe environment. In a military setting
this might include calculation ofrespiratory infection rates in different types ofbar-
racks, or under different training schedules, or according to the size of the recruit
unit, or in relation to the number ofnew recruits mixed in with the old. Host factors
might include age, prior immunity, and genetic characteristics. One host factor we
have measured prospectively in recruits in relation to susceptibility to viral infec-
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tions is that of ABO blood groups. We undertook this study because a previous
English investigation had suggested an ABO relationship (18). They carried out a
retrospective analyses of2000 Royal Air Force recruits with serologically confirmed
respiratory infections in whom they compared the distribution ofABO blood groups
with that of about 50,000 recruits whose blood group had been recorded on induc-
tion. They reported a statistically significant excess of Group A individuals in those
with A2 infections over controls but not with A, B, or Coxsackie infections. This
type of retrospective analysis may have hidden biases and cannot measure the actual
risk of infection according to blood group. We decided to conduct a prospective
study. This was based on the incidence rate of serologically confined respiratory in-
fections in recruits, Peace Corps volunteers, and Yale freshman according to their
ABO blood type. The infection rate was calculated on a fourfold or greater rise in
titer in two sera from the same persons spaced in time (19). In 926 young adults
followed in this way 40.3% had evidence ofinfluenza A2 infections but no significant
difference in the incidence of infection was seen in persons of different ABO blood
groups. Similarly, no significant differences were encounted by blood groups when
the incidence of influenza B, parainfluenza 1-3, adenovirus, and M. pneumoniae in-
fections were analyzed. Thus we were unable to confirm by prospective analysis the
retrospective observations of the English group which had reported a higher fre-
quency ofclinical influenza in persons ofblood group 0 (18).
DISCUSSION
In this paper the advantages, disadvantages, and uses of seroepidemiological sur-
veys of acute respiratory infections in military personnel have been presented using
examples from our own published and unpublished work. The application of this
method to supplement other sources ofmorbidity data is strongly recommended. It
can provide answers to some questions not measurable by case reporting techniques.
These advantages include the identification of susceptibles, the calculation of the
total infection rate (clinical and subclinical), the response to vaccines, and the effect
of various host and environmental factors on the incidence of infection. We have
also applied the technique to investigations ofacute respiratory infections in civilian
groups (10), to community health surveys (20), and to a variety ofprevalence and in-
cidence studies of EB virus and infectious mononucleosis in both civilian (21-23) and
military personnel (24-26).
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